PRLog - Oct. 16, 2012 - LAUSANNE, Switzerland -- The Market for TransCatheter Aortic Valve Repair (TAVR) is probably the fastest growing segment right now in the endovascular sapce.
A new report from Medtech Ventures: TransCatheter Aortic Valves Market, available atL
Predicts a global market of $2.2 billion by 2016 and that is after reviewing the latest 3rd quarter results released from Edwards Lifesciences regarding their sales of the device in the US, Europe and International market.
TAVR has not entered Japan yet and is expected to do so in 2013. Either Edwards or Medtronic will be 1st to market in Japan since both of them have government approved clinical trials programs underway in those countries.
Other companies in the space include St. Jude Medical, JanaValve, Boston Scientific and Symetis from Switzerland.
The report, TransCatheter Aortic Valves Market is the first published account of this market with analysis of both technology and markets and credible forecast to 2012.
The report is available for download at:
Download your copy today.
eReports aggregates premium quality market research reports that are available in electronic format ready for instant download. Each eReport selected is reviewed by eReports knowledgeable infomediaries and checked for consistency, quality and professionalism.
More information can be found online at http://ai.ereports.ch